Critical Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2008

Business Wire, Oct 20, 2008

In addition, the statements in this press release reflect Critical Therapeutics expectations and beliefs only as of the date of this release. Critical Therapeutics anticipates that subsequent events and developments will cause its expectations and beliefs to change. However, while Critical Therapeutics may elect to update these forward-looking statements publicly at some point in the future, the Company specifically disclaims any obligation to do so, except as required by law, whether as a result of new information, future events or otherwise. In general, Critical Therapeutics' forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, business development transactions, joint ventures or investments, except that in particular circumstances as specifically indicated the Company may address the potential impact of the proposed transaction with Cornerstone. These forward-looking statements should not be relied upon as representing the views of Critical Therapeutics as of any date subsequent to the date of this release.

ZYFLO CR([R]) and ZYFLO([R]) are registered trademarks of Critical Therapeutics, Inc.

Financial Tables Follow

[TABLE OMITTED]
[TABLE OMITTED]
[TABLE OMITTED]